Jump to content

Adebayo Alonge

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AppleLagsTheFirst (talk | contribs) at 08:00, 6 October 2023 (Minor punctuation errors). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MNIM
Adebayo Alonge
Adebayo Alonge, 2019.
NationalityNigerian
Other namesSamuel
Alma materKing's College, Lagos
(Senior School Certificate)
University of Ibadan
(Bachelor of Pharmacy)
Lagos Business School
(Master of Business Administration)
Yale School of Management
(Master of Advanced Management)
John F. Kennedy School of Government
(Master of Public Administration)
Graduate School of International Corporate Strategy
(International business)
Known forinvention of RxScanner
AwardsAwards in person from Barack Obama (ex-US president) and Justin Trudeau (prime minister of Canada)[citation needed]

Regional finalist, Hult Prize Global Case Competition

Young Innovator – YouWin!

Grand Winner & Digital Health Winner, Hello Tomorrow Global Challenge 2019

Winner, deep tech Award with a €100,000 prize, 2019

2018 China Award for Best deep tech Platform in the World[citation needed]

Global Social Venture Award (2016) from InnovateHealth, Yale

Mandela Washington Fellowship from the United States Department of State for outstanding contributions to business and entrepreneurship in Africa (2014)

Adekunle Ajasin Award for Academic Excellence in 2008

Adebayo Alonge is a Nigerian pharmacist, inventor, deep tech entrepreneur, and market development professional. He is the winner of the 2019 Hello Tomorrow Global Deeptech Challenge, known as the BNP Paribas Group Deep Tech Award, for creating a handheld nano-scanner that detects counterfeit drugs.

He is now the CEO and co-founder of [1]RxAll Inc. – a U.S. based deep tech start-up firm.[2]

Education

Adebayo Alonge attended King's College, Lagos, between 1996 and 2002. He studied pharmacy at University of Ibadan, and graduated with first class honor in 2008.[3][unreliable source?] He had a Master of Business Administration degree (with focus on Strategy and Finance) from the Lagos Business School - Pan-Atlantic University and holds a Master of Advanced Management from Yale University - Yale School of Management.[4] He is an alumnus of Hitotsubashi University Graduate School of International Corporate Strategy, and currently studying Master of Public Administration (Mason Program) at Harvard Kennedy School - Harvard University.[5]

Career

Adebayo Alonge served in the following capacity as a Medical representative of Sanofi between November 2009 and September 2010, as well as a Contract Pharmacist at Global HIV/AIDS Initiative. He worked as a Medical representative of Roche (currently Swiss Pharma Nigeria) from September 2010 to October 2012, and as a Market Development Intern[6](Pharma Ingredients) of BASF, a German chemical company where he worked from July 2013 to October 2013. He worked as a Market Developer at BASF West Africa from August 2014 to August 2015 as well, and he was a Director of business development at "Lusoy Investments Limited" between April 2012 to October 2017 and during November 2015 to October 2017 he worked as a Consultant at The Boston Consulting Group.

In 2016, Alonge co-founded RxAll Inc. intending to prevent patients from counterfeit medicines and provide a way for them to authenticate their drugs. RxAll. Inc has three co-founders; Alonge as the Chief executive official, Amy Kao as the chief marketing officer, and Wei Liu as the chief technology officer.[7]

Awards, honours and recognition

Adebayo Alonge has received the Adekunle Ajasin Award for Academic Excellence in 2008, the Mandela Washington Fellowship from[8] the United States Department of State for outstanding contributions to business and entrepreneurship in Africa in 2014, and the Global Social Venture Award from InnovateHealth, Yale University in 2016. Adebayo Alonge won the 2018 China Award for Best DeepTech Platform in the World, he also got a €100,000 prize for a DeepTech award. Some of the other things he won were the Grand Winner & Digital Health Winner in 2019, the Hello Tomorrow Global Challenge 2019, the Young Innovator – YouWin!, the Regional finalist, Hult Prize Global Case Competition and awards in person from Barack Obama (ex-president of the United States) and Justin Trudeau (prime minister of Canada).

See also

References

  1. ^ "Fake pharmaceutical industry thrives in West Africa". BBC News. 2020-07-13. Retrieved 2020-08-07.
  2. ^ "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-20.
  3. ^ "Five questions to .... Adebayo Alonge – IFPMA". www.ifpma.org. Retrieved 2020-01-20.
  4. ^ "Adebayo Samuel Alonge". IREX. Retrieved 2020-01-20. [dead link‍]
  5. ^ Xiong, Amy (April 6, 2018). "New startup targets fake drugs". yaledailynews.com. Retrieved 2020-08-07.
  6. ^ "Meet Adebayo Alonge, the Nigeran pharmacist who beat Tech startups from 119 countries to win the grand prize of €100,000". www.pulse.ng. 25 March 2019. Retrieved 2020-01-20.
  7. ^ "Adebayo Alonge". summit.techsauce.co. Retrieved 2020-01-20.
  8. ^ Ekwealor, Victor (2019-03-22). "Nigerian deep tech startup, RxAll is looking to squash the $30 billion global fake drug industry". Techpoint.Africa. Retrieved 2020-01-20.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Adebayo_Alonge&oldid=1178848818"